Pure Bioscience, Inc. (PURE) stock
PUREOTCMiscellaneous Chemical ProductsFiscal year ends July 31
$0.07−0.01 (-12.10%)
Close on Oct 19, 2026Market cap $8.67MP/E –Yield –
Pure Bioscience price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Pure Bioscience's price to sales ratio was 3.7× on Oct 19, 2026, against 3.6× a year earlier. Over the last 5 years it ranged from 2.0× to 12.3×, with a median of 5.3×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Oct 19, 2026 | 3.7× | +1.7 |
| 2025 | Dec 31, 2025 | 2.0× | −2.0 |
| 2024 | Dec 31, 2024 | 4.0× | −2.9 |
| 2023 | Dec 29, 2023 | 6.9× | +1.9 |
| 2022 | Dec 30, 2022 | 5.0× | −1.0 |
| 2021 | Dec 31, 2021 | 6.0× | −2.5 |
| 2020 | Dec 31, 2020 | 8.6× | −5.0 |
| 2019 | Dec 31, 2019 | 13.5× | −0.8 |
| 2018 | Dec 31, 2018 | 14.3× | −22.3 |
| 2017 | Dec 29, 2017 | 36.6× | +2.1 |
| 2016 | Dec 30, 2016 | 34.5× | −31.9 |
| 2015 | Dec 31, 2015 | 66.4× | +27.5 |
| 2014 | Dec 31, 2014 | 38.9× | +5.7 |
| 2013 | Dec 31, 2013 | 33.3× | +23.0 |
| 2012 | Dec 31, 2012 | 10.2× | −9.2 |
| 2011 | Dec 30, 2011 | 19.5× | – |
See a number that looks wrong?